Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules

Overview of attention for article published in Frontiers in Pharmacology, April 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter: 3 X users

So far, Altmetric has seen 7 X posts from 3 X users, with an upper bound of 1,941 followers.

Barakat A, et al. Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules. Front Pharmacol. https://t.co/kNWMvwmskW https://t.co/5JIN2DrVzI

29 Apr 2024

Reply Repost Favourite

Read our publication @FrontPharmacol @Luisrdomingo @EraChair https://t.co/iyowJ2vSyJ

08 Apr 2024

Reply Repost Favourite

RT @Alammari1401: Frontiers | Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidaz…

08 Apr 2024

Reply Repost Favourite

Frontiers | Activation of p53 signaling and regression of breast and prostate carcinoma cells by spirooxindole-benzimidazole small molecules https://t.co/b7LPyvkCUh

08 Apr 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.